Ceftriaxone and Amniotic cavity infection - a phase IV clinical study of FDA data


Amniotic cavity infection is found among people who take Ceftriaxone, especially for people who are 20-29 old.

The phase IV clinical study analyzes which people take Ceftriaxone and have Amniotic cavity infection. It is created by eHealthMe based on reports of 33,453 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 30, 2022

33,453 people reported to have side effects when taking Ceftriaxone.
Among them, 18 people (0.05%) have Amniotic cavity infection.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 33,567 Ceftriaxone users for its effectiveness, alternative drugs and more.

What is Amniotic cavity infection?

Amniotic cavity infection is found to be associated with 269 drugs and 143 conditions by eHealthMe.

Number of Ceftriaxone and Amniotic cavity infection reports submitted per year:

Could Ceftriaxone cause Amniotic cavity infection?

Age of people who have Amniotic cavity infection when taking Ceftriaxone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 54.55 %
  • 30-39: 45.45 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Ceftriaxone *:

  1. Metronidazole: 9 people, 50.00%
  2. Clarithromycin: 5 people, 27.78%
  3. Azithromycin: 4 people, 22.22%
  4. Insulin: 1 person, 5.56%
  5. Dexamethasone: 1 person, 5.56%
  6. Amoxicillin: 1 person, 5.56%

Common side effects people have besides Amniotic cavity infection *:

  1. Maternal Exposure During Pregnancy (use of substance during pregnancy): 12 people, 66.67%
  2. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 4 people, 22.22%
  3. Placental Infarction (interruption of blood supply to a part of the placenta, causing its cells to die): 3 people, 16.67%
  4. Drug Ineffective: 3 people, 16.67%
  5. Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 2 people, 11.11%
  6. Foetal Death (death of foetus): 2 people, 11.11%
  7. Premature Baby: 2 people, 11.11%
  8. Developmental Delay: 1 person, 5.56%
  9. Fever: 1 person, 5.56%
  10. Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 1 person, 5.56%

Common conditions people have *:

  1. Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 4 people, 22.22%
  2. Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water): 4 people, 22.22%
  3. Vaginal Discharge: 2 people, 11.11%
  4. Tocolysis (inhibition of uterine contractions): 2 people, 11.11%
  5. Premature Labor: 1 person, 5.56%
  6. Pneumonia Bacterial (pneumonia associated with bacterial infection): 1 person, 5.56%
  7. Oxygen Saturation Decreased: 1 person, 5.56%
  8. Maternal Therapy To Enhance Foetal Lung Maturity: 1 person, 5.56%
  9. Gestational Diabetes (diabetes in pregnancy): 1 person, 5.56%
  10. Fever: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Amniotic cavity infection?

Check whether Amniotic cavity infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Amniotic cavity infection and when was it recovered:

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Alternative drugs to, pros and cons of Ceftriaxone:

Common Ceftriaxone side effects:

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Amniotic cavity infection treatments and more:

COVID vaccines that are related to Amniotic cavity infection:

Common drugs associated with Amniotic cavity infection:

All the drugs that are associated with Amniotic cavity infection:

All the conditions that are associated with Amniotic cavity infection:

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: